The Discounted Cash Flow (DCF) valuation of Emergent BioSolutions Inc (EBS) is 7.22 USD. With the latest stock price at 5.64 USD, the upside of Emergent BioSolutions Inc based on DCF is 28.1%.
Based on the latest price of 5.64 USD and our DCF valuation, Emergent BioSolutions Inc (EBS) is a buy. buying EBS stocks now will result in a potential gain of 28.1%.
| Range | Selected | |
| WACC / Discount Rate | 6.5% - 8.9% | 7.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 0.78 - 32.15 | 7.22 |
| Upside | -86.2% - 470.0% | 28.1% |